Item 3 is hereby amended and restated to read as follows: The Shares purchased by Stoney Lonesome and Drake Helix were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 633,271 Shares directly owned by Stoney Lonesome is approximately $3,349,904, including brokerage commissions. The aggregate purchase price of the 36,000 Shares directly owned by Drake Helix is approximately $121,947, including brokerage commissions.

Item 4 is hereby amended to add the following: On September 2, 2025, the Reporting Persons issued a presentation (the "Presentation") in connection with the Proposed Merger between the Issuer and Buyerlink. In the Presentation, the Reporting Persons announced their intention to vote against the Proposed Merger and the reasons therefor, including, among others, the Reporting Persons' belief that (i) minority stockholders will suffer immense value destruction, (ii) the Special Committee and the Board's process in approving the Proposed Merger was flawed, (iii) the Issuer's Chairman and CEO Payam Zamani is set to receive a substantial windfall at the expense of minority stockholders and (iv) the combined company will result in a non-sensical conglomerate structure without apparent synergies. The foregoing description of the Presentation is qualified in its entirety by reference to the full text of the Presentation, which is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 5(a) is hereby amended and restated to read as follows: The aggregate percentage of Shares reported owned by each person named herein is based on 12,469,941 Shares outstanding as of August 18, 2025, which is the total number of Shares outstanding as disclosed in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on August 29, 2025. As of the date hereof, Stoney Lonesome directly beneficially owned 633,271 Shares, constituting approximately 5.1% of the Shares outstanding. CCM, as the general partner of Stoney Lonesome, may be deemed the beneficial owner of the 633,271 Shares directly owned by Stoney Lonesome, constituting approximately 5.1% of the Shares outstanding. As of the date hereof, Drake Helix directly beneficially owned 36,000 Shares, constituting approximately 0.3% of the Shares outstanding. CDC Financial, as the managing member of each of CCM and Drake Helix, may be deemed the beneficial owner of the (i) 633,271 Shares directly owned by Stoney Lonesome and (ii) 36,000 Shares directly owned by Drake Helix, constituting approximately 5.4% of the Shares outstanding. Mr. Coghill, as the President and sole shareholder of CDC Financial, may be deemed the beneficial owner of the (i) 633,271 Shares directly owned by Stoney Lonesome and (ii) 36,000 Shares directly owned by Drake Helix, constituting approximately 5.4% of the Shares outstanding. The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each Reporting Person disclaims beneficial ownership of the Shares that he or it does not directly own.

Item 5(c) is hereby amended and restated to read as follows: The transactions in securities of the Issuer by the Reporting Persons since the filing of the Schedule 13D are set forth in Exhibit 2 and are incorporated herein by reference. All of such transactions were effected in the open market unless otherwise noted therein.

2 - Transactions in Securities. 99.1 - Presentation, dated September 2, 2025.